Filtering by:
Small Cell Lung CancerTop Story
March 19, 2019
FDA Approves Tecentriq (Atezolizumab) for Small Cell Lung Cancer
The US Food and Drug Administration (FDA) has approved the immunotherapy drug Tecentriq (atezolizumab) for the treatment of small cell lung cancer (SCLC).
August 17, 2018
FDA Approves Opdivo (Nivolumab) for Small Cell Lung Cancer
The US Food and Drug Administration had approved the immunotherapy drug Opdivo (nivolumab) to treat people with small cell lung cancer (SCLC).